BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12929588)

  • 1. The role of xenografting in pediatric brain tumor research with specific emphasis on medulloblastoma/primitive neuroectodermal tumors of childhood.
    Sterling-Levis K; White L
    In Vivo; 2003; 17(4):329-42. PubMed ID: 12929588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medulloblastoma/primitive neuroectodermal tumour studied as a Matrigel enhanced subcutaneous xenograft model.
    White L; Sterling-Levis K; Kees UR; Tobias V
    J Clin Neurosci; 2001 Mar; 8(2):151-6. PubMed ID: 11484666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
    Leggas M; Stewart CF; Woo MH; Fouladi M; Cheshire PJ; Peterson JK; Friedman HS; Billups C; Houghton PJ
    Clin Cancer Res; 2002 Sep; 8(9):3000-7. PubMed ID: 12231547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
    White L; Sterling-Levis K
    J Clin Neurosci; 2008 Jan; 15(1):49-54. PubMed ID: 18036819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2000; 14(5):675-82. PubMed ID: 11212845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
    Geoerger B; Kerr K; Tang CB; Fung KM; Powell B; Sutton LN; Phillips PC; Janss AJ
    Cancer Res; 2001 Feb; 61(4):1527-32. PubMed ID: 11245461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
    Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
    Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
    Lyons SA; O'Neal J; Sontheimer H
    Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology and molecular pathology of pediatric brain tumors.
    Pfister S; Hartmann C; Korshunov A
    J Child Neurol; 2009 Nov; 24(11):1375-86. PubMed ID: 19841426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primitive neuroectodermal tumor].
    Biernat W
    Pol J Pathol; 2001; 52(4 Suppl):125-34. PubMed ID: 11987598
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system.
    Goussia AC; Bruner JM; Kyritsis AP; Agnantis NJ; Fuller GN
    Anticancer Res; 2000; 20(1A):65-73. PubMed ID: 10769636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of brain tumors to chemotherapy, evaluated in a clinically relevant xenograft model.
    White L; Sterling-Levis K; Fisher R; Tobias V
    J Neurooncol; 1995; 25(1):39-47. PubMed ID: 8523088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 2000; 20(3A):1769-80. PubMed ID: 10928106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of infantile brain tumor.
    Daita G; Yonemasu Y; Sato T
    Noshuyo Byori; 1993; 10(2):135-43. PubMed ID: 7693230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
    Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
    Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
    Fouladi M; Blaney SM; Poussaint TY; Freeman BB; McLendon R; Fuller C; Adesina AM; Hancock ML; Danks MK; Stewart C; Boyett JM; Gajjar A
    Cancer; 2006 Nov; 107(9):2291-7. PubMed ID: 17019740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pediatric preclinical testing program: description of models and early testing results.
    Houghton PJ; Morton CL; Tucker C; Payne D; Favours E; Cole C; Gorlick R; Kolb EA; Zhang W; Lock R; Carol H; Tajbakhsh M; Reynolds CP; Maris JM; Courtright J; Keir ST; Friedman HS; Stopford C; Zeidner J; Wu J; Liu T; Billups CA; Khan J; Ansher S; Zhang J; Smith MA
    Pediatr Blood Cancer; 2007 Dec; 49(7):928-40. PubMed ID: 17066459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.